Anti-IL-23 Reference Antibody (mirikizumab)

Reagent Code: #140223

blur_circular Chemical Specifications

inventory_2 Storage & Handling
Storage -20℃

description Product Description

Used in the treatment of moderate to severe ulcerative colitis and psoriasis by targeting and neutralizing interleukin-23 (IL-23), a key cytokine involved in inflammatory pathways. It helps reduce chronic inflammation and improve symptoms in patients who do not respond adequately to conventional therapies. Also utilized in clinical research as a reference standard for developing biosimilars and evaluating anti-IL-23 drug efficacy.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 50μg
10-20 days ฿4,980.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
Anti-IL-23 Reference Antibody (mirikizumab)
No image available
Used in the treatment of moderate to severe ulcerative colitis and psoriasis by targeting and neutralizing interleukin-23 (IL-23), a key cytokine involved in inflammatory pathways. It helps reduce chronic inflammation and improve symptoms in patients who do not respond adequately to conventional therapies. Also utilized in clinical research as a reference standard for developing biosimilars and evaluating anti-IL-23 drug efficacy.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...